Article Text

OP0079-HPR Effects of a one week multidisciplinary inpatient self-management programme for patients with fibromyalgia: A randomised controlled trial
  1. B. Hamnes1,
  2. I. Kjeken2,
  3. P. Mowinckel2,
  4. K.B. Hagen2,3
  1. 1Hospital for Rheumatic Diseases, Lillehammer
  2. 2National Resource Centre for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital
  3. 3Department of Health Sciences, Institute of Health and Society, University of Oslo, Oslo, Norway


Background The European League Against Rheumatism (EULAR)has developed evidence-based recommendations for management of FM. The recommendations are both pharmacological and non-pharmacological. Non-pharmacological recommendations include multidisciplinary approaches, such as self-management programmes (SMP). SMPs have been developed to assist people with chronic rheumatic diseases in their efforts to cope with their disease in daily life. A review of FM studies shows that SMP with or without exercise gave sustained benefits across a range of outcomes for more than 6 months after completion of the SMP.

Objectives To evaluate effects of a one week multidisciplinary inpatient self-management programme (SMP) on psychological distress, skills as a consumer of health services, self-efficacy, andfunctional and symptomatic consequences of fibromyalgia (FM).

Methods A randomised controlled two-armed, assessor-blinded trial with three-week follow-up to evaluate SMP. Primary outcomes were the General Health Questionnaire (GHQ-20) and the Effective Musculoskeletal Consumer Scale (EC-17), while secondary outcomes included the Fibromyalgia Impact Questionnaire (FIQ) and Self-efficacy scales for pain, function and symptoms (ASES).

Results 150 patients with FM were randomised to one week SMP (n=75) or to a waiting list control group (n=75). Of these, 58 participants in the treatment group and 60 in the control group completed the study. At three weeks’ follow up there was a significant difference in EC-17 (0-100) in favour of the treatment group (mean difference 4.26, 95% CI 0.8 to 7.7, p=0.02). There were no differences between the groups for any of the other outcomes.

Conclusions This study shows that in patients with fibromyalgia the SMP has a small short-term effect on skills and behavior that are important for managing and participating in health care (EC-17).

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.